Search

Your search keyword '"Santos-Laso Á"' showing total 42 results

Search Constraints

Start Over You searched for: Author "Santos-Laso Á" Remove constraint Author: "Santos-Laso Á"
42 results on '"Santos-Laso Á"'

Search Results

2. Cholangiocarcinoma landscape in Europe: Diagnostic, prognostic and therapeutic insights from the ENSCCA Registry

3. The altered serum lipidome and its diagnostic potential for Non-Alcoholic Fatty Liver (NAFL)-associated hepatocellular carcinoma

4. Targeting UBC9-mediated protein hyper-SUMOylation in cystic cholangiocytes halts polycystic liver disease in experimental models

6. Differential effects of FXR or TGR5 activation in cholangiocarcinoma progression

7. SOX17 regulates cholangiocyte differentiation and acts as a tumor suppressor in cholangiocarcinoma

9. Ursodeoxycholic acid inhibits hepatic cystogenesis in experimental models of polycystic liver disease

10. THU-118 Prophylaxis for tuberculosis and pneumocystis jirovecii does not seem necessary in patients with autoimmune hepatitis treated with corticosteroid therapy: spanish multicentre study

11. THU-155 Incidence of fungal and other opportunistic infections in patients with autoimmune hepatitis: a spanish multicentre study

12. THU461 - Serum and urine extracellular vesicles contain specific RNAs with diagnostic capacity for cholangiocarcinoma, being possibly involved in disease pathogenesis

13. SAT-484 - Diagnostic performance of non-invasive fibrosis markers in patients with immune-mediated disease and hepatic steatosis

14. THU076 - The metabolic dysfunction-associated fatty liver disease definition, regardless of its clinical subclassification, identifies patients at high risk for liver disease progression

15. THU074 - Metabolic dysfunction-associated fatty liver disease increases cardiovascular risk regardless of classical risk factors

16. OS157 - Cholangiocarcinoma landscape in Europe: diagnostic, prognostic and therapeutic insights from the ENSCCA Registry

17. Novel protein biomarkers in serum extracellular vesicles for the diagnosis of primary sclerosing cholangitis (PSC) in patients with ulcerative colitis (UC)

18. Serum and urine extracellular vesicles contain mRNA biomarkers for primary sclerosing cholangitis (PSC) and cholangiocarcinoma (CCA)

19. Clinical Outcomes in biopsy-proven NAFLD patients from the HEPAmet Spanish Registry

20. Metabolically unhealthy status impacts on the risk of significant liver injury in biopsy-proven NAFLD patients beyond obesity

21. FRI277 - Proteostasis improvement in cystic cholangiocytes alleviates endoplasmic reticulum stress and halts polycystic liver disease

22. FRI055 - Serum lipidomic landscape of non-alcoholic fatty liver disease progression to hepatocellular carcinoma in a Caucasian population

24. SAT-425-Serum metabolites as diagnostic biomarkers for cholangiocarcinoma, hepatocellular carcinoma and primary sclerosing cholangitis

25. SAT-296-Oxidized LDL is a distinctive biomarker of NASH independently of liver fibrosis in patients with NAFLD

27. Serum extracellular vesicles contain protein biomarkers for primary sclerosing cholangitis and cholangiocarcinoma

28. SAT-507 - Metabolically unhealthy status impacts on the risk of significant liver injury in biopsy-proven NAFLD patients beyond obesity

29. SAT-508 - Clinical Outcomes in biopsy-proven NAFLD patients from the HEPAmet Spanish Registry

30. FRI-164 - Serum and urine extracellular vesicles contain mRNA biomarkers for primary sclerosing cholangitis (PSC) and cholangiocarcinoma (CCA)

31. THU-206 - Novel protein biomarkers in serum extracellular vesicles for the diagnosis of primary sclerosing cholangitis (PSC) in patients with ulcerative colitis (UC)

32. PS-179 - Hepamet Score: a new non-invasive method for NAFLD-related fibrosis screening in clinical practice

33. Overexpression of Mirna-506 in Human Cholangiocytes Causes Primary Biliary Cholangitis-Like Features including Mitochondrial Dysfunction and Increased Sensitivity to Apoptosis

34. P1182 : MIR-506 is upregulated by pro-inflammatory cytokines in human cholangiocytes and inhibits cell proliferation and adhesion

36. THU-074 - Serum extracellular vesicles contain protein biomarkers for primary sclerosing cholangitis and cholangiocarcinoma

37. SAT-365 - Overexpression of Mirna-506 in Human Cholangiocytes Causes Primary Biliary Cholangitis-Like Features including Mitochondrial Dysfunction and Increased Sensitivity to Apoptosis

40. miR-21-5p promotes NASH-related hepatocarcinogenesis.

41. Faecal Microbiota Transplantation, Paving the Way to Treat Non-Alcoholic Fatty Liver Disease.

42. Adiponectin, Leptin, and IGF-1 Are Useful Diagnostic and Stratification Biomarkers of NAFLD.

Catalog

Books, media, physical & digital resources